Elevate Your Clinical Lab with Unparalleled Value

The basis of TRACE technology is non-radiative energy transfer from a donor to an acceptor, which is part of a chemically modified, light-collecting algal protein (e.g. XL 665). The spectral overlap between donor emission and acceptor absorption spectra on the one hand, intensify the fluorescent signal of the cryptate and on the other hand, extend the life span of the acceptor signal, permitting the measurement of temporally delayed fluorescence. TRACE ensures that only signals of interests are measured by excluding unbound and unspecific signals.

Fast, accurate and reliable lab test results enable confident clinical decisions. Delays in reporting results can often have detrimental impacts on both patient and healthcare provider, and as such, turnaround time is a key performance indicator of well-functioning laboratories.

A frequent challenge to reporting results quickly is the accurate measurement and processing of an out-of range (OOR) sample. Utilizing Nobel Prize winning TRACE technology, it is now possible to eliminate unnecessary manual processing steps in OOR sample management and optimize turnaround time.

B·R·A·H·M·S KRYPTOR Analyzers are the only immunoanalyzers in the market that fully automate all necessary steps which are required for a dilution. Using Nobel Prize winning TRACE (Time Resolved Amplified Cryptate Emission) technology, B·R·A·H·M·S KRYPTOR Analyzers can detect the OOR samples within a few minutes of the incubation period and carry out the dilution without any user intervention. This unique feature, which optimizes laboratory workflow, is named “Self-determining dilution factor” (SDDF).